NCT02495311

Brief Summary

The aim of this study is to assess the relationship between adenomyosis/myoma and lower urinary tract symptoms, sexual function and gastrointestinal symptoms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 13, 2015

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

10.1 years

First QC Date

July 4, 2015

Last Update Submit

September 14, 2023

Conditions

Keywords

adenomyosisuterine myomalower urinary tract symptomssexual dysfunctiongastrointestinal symptom

Outcome Measures

Primary Outcomes (1)

  • The corrleation coefficient between the size of myoma and Overactive Bladder Symptoms Scores

    The Spearman's correlation between the size of uterine myoma and the score of Overactive Bladder Symptoms Scores

    12 weeks

Secondary Outcomes (3)

  • The corrleation coefficient between the size of myoma and the presence of constipation/diarrhea

    12 weeks

  • Comparison of Overactive Bladder Symptoms Scores between the adenomyosis group and the control group

    12 weeks

  • Comparisons of the constipation/diarrhea rates between the adenomyosis group and the control group

    12 weeks

Study Arms (3)

Women with uterine myoma

Women with uterine myoma

Procedure: myomectomy or adenomyomectomy

Women with adenomyosis

Women with adenomyosis

Procedure: myomectomy or adenomyomectomy

Women without uterine myoma or adenomyosis

Control group

Interventions

Women with adenomyosisWomen with uterine myoma

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with uterine myoma or adenomyosis

You may qualify if:

  • \>20 years old.
  • Myoma: women with \>3 cm uterine myoma
  • Adenomyosis: women with uterus having several dark area (lacunar areas) in one uterine wall or thickening uterine wall
  • \<The control group\>
  • \>20 years old.
  • Women without myoma or adenomyosis
  • \<Both groups\>

You may not qualify if:

  • The patient has a lower urinary tract infection or acute intestinal inflammation.
  • Previous surgery for the bladder or urethra.
  • History of urinary tract stones or tumors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Far-Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

RECRUITING

MeSH Terms

Conditions

AdenomyosisMyofibromaLower Urinary Tract SymptomsSexual Dysfunction, Physiological

Interventions

Uterine Myomectomy

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsConnective Tissue DiseasesSkin and Connective Tissue DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Gynecologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Sheng-Mou Hsiao, MD

    Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sheng-Mou Hsiao, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Obstetrics & Gynecology

Study Record Dates

First Submitted

July 4, 2015

First Posted

July 13, 2015

Study Start

November 15, 2014

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 15, 2023

Record last verified: 2023-09

Locations